Copyright Reports & Markets. All rights reserved.

Global Lung Cancer Therapy Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Lung Cancer Therapy Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Lung Cancer Therapy Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Radiation Therapy
    • 1.4.3 Chemotherapy
    • 1.4.4 Targeted Therapies
    • 1.4.5 Immunotherapy
  • 1.5 Market by Application
    • 1.5.1 Global Lung Cancer Therapy Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): Lung Cancer Therapy Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Lung Cancer Therapy Industry
      • 1.6.1.1 Lung Cancer Therapy Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Lung Cancer Therapy Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Lung Cancer Therapy Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Lung Cancer Therapy Market Perspective (2015-2026)
  • 2.2 Lung Cancer Therapy Growth Trends by Regions
    • 2.2.1 Lung Cancer Therapy Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Lung Cancer Therapy Historic Market Share by Regions (2015-2020)
    • 2.2.3 Lung Cancer Therapy Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Lung Cancer Therapy Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Lung Cancer Therapy Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Lung Cancer Therapy Players by Market Size
    • 3.1.1 Global Top Lung Cancer Therapy Players by Revenue (2015-2020)
    • 3.1.2 Global Lung Cancer Therapy Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Lung Cancer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Lung Cancer Therapy Market Concentration Ratio
    • 3.2.1 Global Lung Cancer Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Lung Cancer Therapy Revenue in 2019
  • 3.3 Lung Cancer Therapy Key Players Head office and Area Served
  • 3.4 Key Players Lung Cancer Therapy Product Solution and Service
  • 3.5 Date of Enter into Lung Cancer Therapy Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Lung Cancer Therapy Historic Market Size by Type (2015-2020)
  • 4.2 Global Lung Cancer Therapy Forecasted Market Size by Type (2021-2026)

5 Lung Cancer Therapy Breakdown Data by Application (2015-2026)

  • 5.1 Global Lung Cancer Therapy Market Size by Application (2015-2020)
  • 5.2 Global Lung Cancer Therapy Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Lung Cancer Therapy Market Size (2015-2020)
  • 6.2 Lung Cancer Therapy Key Players in North America (2019-2020)
  • 6.3 North America Lung Cancer Therapy Market Size by Type (2015-2020)
  • 6.4 North America Lung Cancer Therapy Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Lung Cancer Therapy Market Size (2015-2020)
  • 7.2 Lung Cancer Therapy Key Players in Europe (2019-2020)
  • 7.3 Europe Lung Cancer Therapy Market Size by Type (2015-2020)
  • 7.4 Europe Lung Cancer Therapy Market Size by Application (2015-2020)

8 China

  • 8.1 China Lung Cancer Therapy Market Size (2015-2020)
  • 8.2 Lung Cancer Therapy Key Players in China (2019-2020)
  • 8.3 China Lung Cancer Therapy Market Size by Type (2015-2020)
  • 8.4 China Lung Cancer Therapy Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Lung Cancer Therapy Market Size (2015-2020)
  • 9.2 Lung Cancer Therapy Key Players in Japan (2019-2020)
  • 9.3 Japan Lung Cancer Therapy Market Size by Type (2015-2020)
  • 9.4 Japan Lung Cancer Therapy Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Lung Cancer Therapy Market Size (2015-2020)
  • 10.2 Lung Cancer Therapy Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Lung Cancer Therapy Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Lung Cancer Therapy Market Size by Application (2015-2020)

11 India

  • 11.1 India Lung Cancer Therapy Market Size (2015-2020)
  • 11.2 Lung Cancer Therapy Key Players in India (2019-2020)
  • 11.3 India Lung Cancer Therapy Market Size by Type (2015-2020)
  • 11.4 India Lung Cancer Therapy Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Lung Cancer Therapy Market Size (2015-2020)
  • 12.2 Lung Cancer Therapy Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Lung Cancer Therapy Market Size by Type (2015-2020)
  • 12.4 Central & South America Lung Cancer Therapy Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 GlaxoSmithKline
    • 13.1.1 GlaxoSmithKline Company Details
    • 13.1.2 GlaxoSmithKline Business Overview and Its Total Revenue
    • 13.1.3 GlaxoSmithKline Lung Cancer Therapy Introduction
    • 13.1.4 GlaxoSmithKline Revenue in Lung Cancer Therapy Business (2015-2020))
    • 13.1.5 GlaxoSmithKline Recent Development
  • 13.2 Menarini
    • 13.2.1 Menarini Company Details
    • 13.2.2 Menarini Business Overview and Its Total Revenue
    • 13.2.3 Menarini Lung Cancer Therapy Introduction
    • 13.2.4 Menarini Revenue in Lung Cancer Therapy Business (2015-2020)
    • 13.2.5 Menarini Recent Development
  • 13.3 Pfizer
    • 13.3.1 Pfizer Company Details
    • 13.3.2 Pfizer Business Overview and Its Total Revenue
    • 13.3.3 Pfizer Lung Cancer Therapy Introduction
    • 13.3.4 Pfizer Revenue in Lung Cancer Therapy Business (2015-2020)
    • 13.3.5 Pfizer Recent Development
  • 13.4 Roche
    • 13.4.1 Roche Company Details
    • 13.4.2 Roche Business Overview and Its Total Revenue
    • 13.4.3 Roche Lung Cancer Therapy Introduction
    • 13.4.4 Roche Revenue in Lung Cancer Therapy Business (2015-2020)
    • 13.4.5 Roche Recent Development
  • 13.5 Merck
    • 13.5.1 Merck Company Details
    • 13.5.2 Merck Business Overview and Its Total Revenue
    • 13.5.3 Merck Lung Cancer Therapy Introduction
    • 13.5.4 Merck Revenue in Lung Cancer Therapy Business (2015-2020)
    • 13.5.5 Merck Recent Development
  • 13.6 AstraZeneca
    • 13.6.1 AstraZeneca Company Details
    • 13.6.2 AstraZeneca Business Overview and Its Total Revenue
    • 13.6.3 AstraZeneca Lung Cancer Therapy Introduction
    • 13.6.4 AstraZeneca Revenue in Lung Cancer Therapy Business (2015-2020)
    • 13.6.5 AstraZeneca Recent Development
  • 13.7 Sanofi-Aventis
    • 13.7.1 Sanofi-Aventis Company Details
    • 13.7.2 Sanofi-Aventis Business Overview and Its Total Revenue
    • 13.7.3 Sanofi-Aventis Lung Cancer Therapy Introduction
    • 13.7.4 Sanofi-Aventis Revenue in Lung Cancer Therapy Business (2015-2020)
    • 13.7.5 Sanofi-Aventis Recent Development
  • 13.8 Eli Lilly and Company
    • 13.8.1 Eli Lilly and Company Company Details
    • 13.8.2 Eli Lilly and Company Business Overview and Its Total Revenue
    • 13.8.3 Eli Lilly and Company Lung Cancer Therapy Introduction
    • 13.8.4 Eli Lilly and Company Revenue in Lung Cancer Therapy Business (2015-2020)
    • 13.8.5 Eli Lilly and Company Recent Development
  • 13.9 Abbott
    • 13.9.1 Abbott Company Details
    • 13.9.2 Abbott Business Overview and Its Total Revenue
    • 13.9.3 Abbott Lung Cancer Therapy Introduction
    • 13.9.4 Abbott Revenue in Lung Cancer Therapy Business (2015-2020)
    • 13.9.5 Abbott Recent Development
  • 13.10 Akebia Therapeutics
    • 13.10.1 Akebia Therapeutics Company Details
    • 13.10.2 Akebia Therapeutics Business Overview and Its Total Revenue
    • 13.10.3 Akebia Therapeutics Lung Cancer Therapy Introduction
    • 13.10.4 Akebia Therapeutics Revenue in Lung Cancer Therapy Business (2015-2020)
    • 13.10.5 Akebia Therapeutics Recent Development
  • 13.11 Agennix AG
    • 10.11.1 Agennix AG Company Details
    • 10.11.2 Agennix AG Business Overview and Its Total Revenue
    • 10.11.3 Agennix AG Lung Cancer Therapy Introduction
    • 10.11.4 Agennix AG Revenue in Lung Cancer Therapy Business (2015-2020)
    • 10.11.5 Agennix AG Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Lung Cancer Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lung Cancer Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    GlaxoSmithKline
    Menarini
    Pfizer
    Roche
    Merck
    AstraZeneca
    Sanofi-Aventis
    Eli Lilly and Company
    Abbott
    Akebia Therapeutics
    Agennix AG

    Market segment by Type, the product can be split into
    Radiation Therapy
    Chemotherapy
    Targeted Therapies
    Immunotherapy
    Market segment by Application, split into
    Hospitals
    Clinics
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Lung Cancer Therapy status, future forecast, growth opportunity, key market and key players.
    To present the Lung Cancer Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Lung Cancer Therapy are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now